Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLS vs GSK✓SelectedUSD · GSKCLS vs GSK performance historyLatest closeAs of-16.00%11/20
Stock and ETF performance explorer

CLS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,543.3%
GSK return
+97.4%
Excess return
+1,445.9%
Maximum drawdown
-80.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-16.0%-0.1%-15.9%-16.0%
7D-16.0%-5.3%-10.7%-14.9%
30D-33.8%-3.7%-30.1%-33.4%
3M-33.2%-7.3%-25.9%-32.3%
6M-41.8%-4.2%-37.5%-42.1%
YTD-31.7%+0.9%-32.6%-33.5%
1Y-28.5%+7.3%-35.8%-31.9%
3Y+617.4%+52.7%+564.6%+461.6%
5Y+1,698.6%+40.1%+1,658.5%+1,331.3%
All+1,543.3%+97.4%+1,445.9%+1,055.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling